A phase III randomized, controlled study to evaluate the safety and efficacy of PANVAC-VF in combination with GM-CSF versus best supportive care or palliative chemotherapy in patients with metastatic (stage IV) adenocarcinoma of the pancreas who have failed a gemcitabine-containing chemotherapy regimen

Trial Profile

A phase III randomized, controlled study to evaluate the safety and efficacy of PANVAC-VF in combination with GM-CSF versus best supportive care or palliative chemotherapy in patients with metastatic (stage IV) adenocarcinoma of the pancreas who have failed a gemcitabine-containing chemotherapy regimen

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2007

At a glance

  • Drugs CV 301 (Primary) ; Granulocyte macrophage colony stimulating factor
  • Indications Pancreatic cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 28 Jun 2007 Interim results have been reported.
    • 18 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top